Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McClellan to start after elections

This article was originally published in The Tan Sheet

Executive Summary

Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. Currently a White House health policy advisor, McClellan was cleared by the Senate Oct. 17 (1"The Tan Sheet" Oct. 21, 2002, In Brief)...

You may also be interested in...

FDA Commissioner McClellan

White House health and economic advisor Mark McClellan, MD/PhD, unanimously confirmed by Senate Oct. 17 after Health Committee member Jeff Bingaman (D-N.M.) lifted hold on nomination (1"The Tan Sheet" Oct. 14, 2002, p. 7). Confirmation comes 21 months after former Commissioner Jane Henney, MD, left office. Although no swearing-in date had been set as of Oct. 18, FDA's Science Board meeting in Rockville, Md. Oct. 25 could mark his first public appearance as commissioner. Meeting agenda lists introductory remarks to be given by McClellan "pending confirmation." Meeting will include discussion of CFSAN counterterrorism efforts, CDER's drug GMP initiative...

Henlius Partners With Mabxience On Trastuzumab

Henlius has struck a deal with Mabxience to market its HLX02 trastuzumab biosimilar in Argentina, Uruguay and Paraguay.

European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake

The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts